Zheng, Guoqiao
Chattopadhyay, Subhayan
Sundquist, Kristina
Sundquist, Jan
Försti, Asta
Hemminki, Akseli
Hemminki, Kari
Funding for this research was provided by:
Deutsches Krebsforschungszentrum (DKFZ)
Article History
Received: 10 June 2021
Accepted: 3 October 2021
First Online: 19 October 2021
Declarations
:
: We secured ethical approval and waiver of informed consent (February 6, 2013) for this study from the Regional Ethical Review Board of Lund University (Dnr 2012/795). All methods were performed in accordance with the relevant guidelines and regulations.
: Not applicable.
: A.H. is shareholder in Targovax ASA. A.H. is employee and shareholder in TILT Biotherapeutics Ltd. Other authors declared no conflict of interest.